News

Strategy outlined for treating severe refractory cutaneous lupus

Publish date: May 16, 2013

 

AT THE SLE INTERNATIONAL CONGRESS

The CLASI copyright is owned by the University of Pennsylvania, Dr. Werth’s institution. Dr. Werth disclosed financial relationships with Pfizer, Novartis, Cephalon, Rigel, and Medimmune, and grant support from Celgene and Amgen.

Pages

Recommended Reading

Eczema of the eyelids? Think chemical allergy
MDedge Internal Medicine
The nose knows: Improved rhinophyma with fractional CO2 ablation
MDedge Internal Medicine
USPSTF: Screen All Patients Aged 15-65 for HIV
MDedge Internal Medicine
Therapeutic combos make inroads in advanced melanoma
MDedge Internal Medicine
Prophylactic penicillin reduces leg cellulitis recurrences
MDedge Internal Medicine
Polymorphic light eruption: A diagnosis of exclusion
MDedge Internal Medicine
In acne, diet is a probable factor
MDedge Internal Medicine
Preimmunosuppresive hepatitis B screening often goes by the wayside
MDedge Internal Medicine
FDA: Tanning lamps should warn against skin cancer
MDedge Internal Medicine
Sjögren's syndrome has high long-term complication rate
MDedge Internal Medicine